| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2971914 | The Journal of Heart and Lung Transplantation | 2009 | 6 Pages |
Abstract
Children with HCM listed for HTx age < 1 year and UNOS status 1 have the highest mortality awaiting HTx. A more rigorous identification of additional risk factors should be performed to better define timing of listing and which patient sub-group may derive optimal benefit from HTx.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Robert MD, David C. PhD, Elfriede MD, Juan MD, F. Bennett MD, James K. MD, Mary CPNP, Anne I. MD, Pediatric Heart Transplant Study Investigators Pediatric Heart Transplant Study Investigators,